CancerNetwork Members: Login | Register
Become a fan on  Facebook  Add us on  Google Plus Follow us on  Twitter Join us on LinkedIn Sign up for our Newsletters Subscribe to our RSS Feed

 

CancerNetwork SearchMedica Medline Drugs

Powered by SearchMedica

 
PUBLICATIONS
NEWS
PODCASTS
TOPICS
BLOGS
NURSES
PATIENTS
JOBS
CONFERENCES
CME
SUPPLEMENTS
 

Home » Gastrointestinal Cancers » Colorectal Cancer

Diagnostic Imaging. Vol. 31 No. 7
 

Medical community must challenge CTC foot-dragging

July 1, 2009

Medical community must challenge CTC foot-dragging

To the Editor,

I couldn't agree more with your editorial on the Centers for Medicare and Medicaid Services and CT colonography ("U.S. needs more colon cancer screening options, not fewer," page 5, May). I submitted my thoughts to CMS pre- and post-Feb. 11, and I'm just flabbergasted that the people making these decisions are still dragging their feet on virtual colonoscopy. We've been doing these procedures for the last seven years, our radiologist has read thousands of these studies, and we work closely with the gastroenterology community to take care of their compromised patients, failed and incomplete procedures, and our patients who need therapeutic procedures.

(MORE: CT colonography tops colonoscopy for mapping colon cancer segmentation)

My only conclusion is that the CMS group must be in the nonpracticing world. Do they not know or calculate the millions of dollars CMS spends on removing benign polyps? Most polyps that are removed in that setting because "we're already in here" and "it increases our reimbursement" are benign; we are only adding risk for the patient. Nobody ever seems to mention that with CT colonography we identify small polyps below even the 6-mm threshold and—without any additional cost or risk to the patient—simply recommend that we repeat the exam in five years to see if there are any changes.

In our experience, about 97% of "screening" exams turn up no polyps. Of course, we do identify other treatable problems and report them. But we have efficiently and cost-effectively been able to sort out patients who are not currently at risk. Those who have masses or cancer can often go right to surgery, as we already have the CT images needed.

I wish there were a way to deluge the CMS committee with real-life pressure to act now and not leave the aging population hanging another year or decade. Unfortunately, much of the problem lies with members of a silent medical community who go about their work and never make the effort to share their views or experience.

Can you believe that only 100 people from all across the country weighed in before Feb. 11 on the subject? Shame on us. We have the knowledge and the power, and we fail to use it to move the CMS mountain.

Tony Finch, MA, MPH
Owner/Administrator
BodyView Diagnostic Scanning
Clackamas, OR

Report ignores the benefits of outpatient imaging centers

To the Editor,

I just read your article about hospitals missing out on revenue due to outpatient imaging centers ("Hospitals lose out when imaging moves to private offices," published online Feb. 18 at www.diagnosticimaging.com/news). The article even stated that this was bad for the healthcare system. It neglected to address the fact that hospitals are reimbursed at a higher rate than outpatient facilities and charge substantially more. We offer services for people at a much more reasonable rate and, because of lower reimbursement, cost the healthcare system less overall. It's a win-win situation, especially for people who have no insurance.

Tina Cobb, RDMS, RVT
Lake Jackson, TX
Edgy NSF article may have gone too far

To the Editor:

I read with interest your article on nephrogenic systemic fibrosis and the "heavy collateral damage" that radiologists face due to the off-label use of gadolinium agents and subsequent development of NSF in some patients ("Radiologists meet with heavy collateral damage," December, page 23). While the points are largely difficult to dispute, I just want to note that there is a lot that we do that is off-label in interventional radiology, such as the way that stents are utilized (FDA concerns noted).

The rhetoric in the article is a bit inflammatory, suggesting that radiologists are to be shamed for ignorance or worse, when most are likely to be well educated and following standards of care that are taught by leaders and mentors in our fields. A similar type of discussion has been going on for some time now regarding ionizing radiation in CT scans, with polarizing viewpoints [expressed in ways] that at times seem more like pointing fingers than actually facilitating constructive dialogue. A toning down of the accusatorial commentary may be appreciated by some of your readers.

Jason Smith, M.D.
Assistant Professor
Department of Radiology
Loma Linda University
Loma Linda, CA

Diagnostic Imaging welcomes letters to the editor. If you have thoughts about opinions or other material presented in Diagnostic Imaging, or about developments in the world of medical imaging, please send them
via e-mail: john.hayes@cmpmedica.com
fax: 415/947-6099
or mail: 600 Harrison St.
San Francisco, CA 94107
Please include a telephone number.

 

Join the Conversation

Want to join the conversation? If you're a healthcare professional, we'd like to hear your comments. Just sign in or register today to become part of our growing, online community.

CT colonography tops colonoscopy for mapping colon cancer segmentation

Journal article reveals much on CMS CT colonography decision

Medical community must challenge CTC foot-dragging

U.S. needs more colon cancer screening options, not fewer

CMS rules against Medicare payment for CT colonography

CT colonography tops colonoscopy for mapping colon cancer segmentation






 
RELATED CONTENT

Staying Fit Could Ward Off Lung and Colorectal Cancer for Middle-Age Men
May 20, 2013
Axitinib Fails to Improve Survival in Metastatic Colorectal Cancer
May 6, 2013
A 47-Year-Old Patient With Chronic Abdominal Pain
April 26, 2013
Endometrial Cancer at Young Age Ups Risk for Colorectal Cancer
April 22, 2013
Smoking Linked to Poorer Prognosis in Colon Cancer
April 13, 2013
 
TOPIC INDEX

Cancer Types

 
  • Breast
  • Breast (HER2+)
  • Breast (Triple-Negative)
  • CML
  • Colorectal
  • Gastrointestinal
  • GIST
  • Genitourinary
  • Gynecologic
  • Head & Neck
  • Hematology
  • Kidney (Renal Cell)
  • Leukemia
  • Lung
  • Lymphoma
  • Melanoma
  • Multiple Myeloma
  • Ovarian
  • Prostate
  • Sarcoma

Supportive Care

More Topics

  • Bone Metastases
  • End-of-Life Care
  • Palliative Care
  • Ethics in Oncology
  • Practice Management
  • Practice & Policy


All Topics 


 
   SEARCH MEDICA RX
   Browse drugs by name:
A B C D E F G H I J
K L M N O P Q R S T
U V W X Y Z All      
   Search for drugs:
Search

 

 
FROM PHYSICIANS PRACTICE
Primary Care Can't Thrive Without Nurse Practitioners
Courtney H. Lyder, ND,  May 17, 2013
With a projected shortfall of primary-care physicians, it's time for alternate solutions to patient care. Nurse practitioners are one logical remedy.
VWhat Physicians Can Learn from the Allscripts EHR Lawsuit
Marisa Torrieri,  May 16, 2013
Lawsuit prompts question: What should physicians do to ensure they end up with a great EHR instead of buyer’s remorse?
Eight Ways ICD-9 Will Still Matter to Medical Practices
Brenda Edwards, CPC,  May 15, 2013
What should your medical practice do with your ICD-9-CM book after October 1, 2014? Keep it.
Seven Ways Technology Can Speed Up Patient Collections
Cheyenne Brinson,  May 15, 2013
Failing to adopt widely available billing and collections technology can cost medical practices big. Here's how to do it right.
Four Reasons Private Medical Practice is Becoming Extinct
Carol Stryker,  May 15, 2013
It’s becoming increasingly difficult for private medical practices to thrive. Here’s what’s driving the trend toward consolidation.
 

 

 
MOST POPULAR
  • Most Popular
  • Most Emailed
  • Most Recent
  • Colorectal Lesions
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • “This Is My Last Day on Earth”
  • Slide Show: Squamous Cell Carcinoma of the Head and Neck
  • The ABCDEs of Moles and Melanomas
  • “This Is My Last Day on Earth”
  • Recurrent Epithelial Ovarian Cancer: An Update on Treatment
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • Colorectal Lesions
  • ONS: Understanding Spirituality and How It Can Be Used to Help Patients
  • Bone Metastases
  • Palliative Radiotherapy in Elderly Patients With Bone Metastases Improves Quality of Life
  • Staying Fit Could Ward Off Lung and Colorectal Cancer for Middle-Age Men
  • Obesity Impairs Efficacy of L-Asparaginase in Leukemia Treatment
  • New AUA Guidelines for Prostate Cancer Screening
Click here to subscribe to our newsletter
 
COMMENTS
  • Most Commented
  • Most Recent
  • “This Is My Last Day on Earth”
  • Financial Toxicity, Part II: How Can We Help With the Burden of Treatment-Related Costs?
  • Patient Quality of Life Endpoints in Oncology Trials, Part II
  • Who's Coding Whom?
  • “How Do I Say This Nicely? Your Oncologist Wasn't Following Guidelines”
  • Preventing Exposure to Hazardous Drugs
  • Cancer Metabolism as a Therapeutic Target
  • Study: Cholesterol Drugs Reduced Risk of Prostate Cancer Death
  • “This Is My Last Day on Earth”
  • ONS: Safe Handling of Chemotherapy
Click here to subscribe to our newsletter


 
SEARCH MEDICA SEARCH RESULT

Find peer-reviewed literature and websites for practicing medical professionals

CME on Colorectal Cancer
Evidence on Colorectal Cancer
Guidelines on Colorectal Cancer
Patient Education on Colorectal Cancer
Clinical Trials on Colorectal Cancer
Practical Articles on Colorectal Cancer
Research and Reviews on Colorectal Cancer
All "Colorectal Cancer" results


CancerNetwork | ConsultantLive | Diagnostic Imaging | Musculoskeletal Network | OBGYN.net | PediatricsConsultantLive |
Physicians Practice | Psychiatric Times | SearchMedica | Medical Resources

© 1996 - 2013 UBM Medica LLC, a UBM company
Privacy Statement - Terms of Service - Advertising Information - Editorial Policy Statement - UBM Medica Network Privacy Policy